TD Cowen Maintains Buy on Boston Scientific, Lowers Price Target to $56

Benzinga · 1d ago
TD Cowen analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $61 to $56.